Funding Received
$12.9 Million in 2 Rounds from 7 Investors
Most Recent Funding
$7.9 Million Series C on September 21, 2010
Founded:
2002
Headquarters:
Ludwigshafen Am Rhein-oggersheim
Description:
Phenex Pharmaceuticals is a drug discovery and development company focused on developing novel pharmaceuticals.
Categories:
Biotechnology
Website:
http://www.phenex-pharma.com

Detailed Description

Update

Phenex is a privately financed biotechnology company that focuses on developing novel drug candidates that act on Nuclear Receptors, a pharmacologically well accepted drug target class. Nuclear receptors are of major importance for the body's homeostasis, as they integrate different intra- and extracellular signalling to initiate and regulate gene expression programs. This key role in a wide variety of signalling pathways qualifies them as important pharmacological targets. Nuclear receptor modulating drugs account for about 10% revenues of the total ethical drug market, applied in different indications, such as Hormone Replacement Therapy, Women's Health, Inflammation, Diabetes, Cancer and Dermatology.

Current Team (9)

Update

Investors (7)

Update

Offices/Locations (2)

Update
  • Research Site

    Waldhofer Str. 104

    Heidelberg, 69123

    DEU

  • Head Office

    Donnersbergweg 1

    Ludwigshafen Am Rhein-oggersheim, 67059

    DEU

Images (1)

Update
  • 2b2441c19f27286095a72a6bd21e6c9c